牡丹颗粒抗施万细胞损伤的有效成分及保护作用
该研究采用UPLC-QTOF-MS鉴定牡丹颗粒中136种成分,并在高糖高脂诱导的施万细胞损伤模型中筛选出7种有效成分。牡丹颗粒通过下调ERK1/2磷酸化和COX-2表达、上调SIRT2表达发挥保护作用,其中6种成分抑制ERK1/2磷酸化。
要点
- 牡丹颗粒含136种成分,筛选出7种保护施万细胞的有效成分。
- 牡丹颗粒下调ERK1/2磷酸化和COX-2、上调SIRT2。
- 6种有效成分抑制ERK1/2磷酸化,丹酚酸B除外。
核心结论
- 牡丹颗粒通过下调ERK1/2磷酸化和COX-2表达、上调SIRT2表达保护施万细胞对抗高糖高脂损伤。
研究设计与样本
- 采用UPLC-QTOF-MS鉴定牡丹颗粒化学成分,并在体外高糖高脂诱导的施万细胞损伤模型中筛选有效成分和研究保护通路。
主要发现
- 共鉴定出136种成分,筛选出7种有效成分,包括三七中的20(R)-人参皂苷Rh2、20(S)-人参皂苷Rh2和人参皂苷Rk3,黄芪中的黄芪甲苷II,丹参中的丹参素,川芎中的绿原酸和隐绿原酸。
- 牡丹颗粒下调ERK1/2磷酸化和COX-2表达,上调SIRT2表达。
- 除丹参素外,其余6种化合物均抑制ERK1/2磷酸化;黄芪甲苷II和绿原酸上调SIRT2表达;隐绿原酸和丹参素下调COX-2表达。
临床怎么用
- 牡丹颗粒可作为糖尿病周围神经病变的潜在治疗药物,其保护施万细胞的机制涉及ERK1/2、COX-2和SIRT2通路。
- 筛选出的7种有效成分可为牡丹颗粒的质量控制提供候选指标。
局限性
- 研究仅基于体外细胞模型,未涉及体内实验和临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes. Mudan granules (MD) is a Chinese patent medicine for treating DPN, which is composed of nine Chinese medicinal herbs, including the radix of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao or Astragalus membranaceus (Fisch.) Bge. (Huangqi in Chinese), rhizome of Corydalis yanhusuo W.T. Wang (Yanhusuo), radix and rhizome of Panax notoginseng (Burk.) F. H. Chen (Sanqi), radix of Paeonia lactiflora Pall. or Paeonia veitchii Lynch (Chishao), radix and rhizome of Salvia miltiorrhiza Bge. (Danshen), rhizome of Ligusticum chuanxiong Hort. (Chuanxiong), flowers of Carthamus tinctorius L. (Honghua), lignum of Caesalpinia sappan L. (Sumu), and caulis of Spatholobus suberectus Dunn (Jixueteng). MD was reported to have a protective effect on Schwann cell (SC) that is considered as an important therapeutic target of DPN. However, the constituents of MD have not been reported, and the effective constituents and protective pathways for MD against SC injury remain unclear. AIM OF THE STUDY: This study aimed to identify the constituents in MD, and to investigate the effective constituents and protective pathways of MD against high-glucose/lipid injury in SC. MATERIALS AND METHODS: The chemical constituents of MD were identified using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). Protective effect and effective constituents screening were performed in an in vitro SC injury model induced by high glucose and lipid levels. The protective pathways of MD and its effective constituents were investigated by western blotting assay of related proteins. RESULTS: A total of 136 constituents were identified in MD. MD downregulated the phosphorylation of extracellular-regulated protein kinases 1/2 (ERK1/2) and expression of cyclooxygenase-2 (COX-2) and upregulated the expression of sirtuin 2 (SIRT2). Seven effective constituents were screened out, including three from Sanqi [20(R)-ginsenoside Rh2, 20(S)-ginsenoside Rh2, and ginsenoside Rk3], one from Huangqi (astragaloside II), one from Danshen (danshensu), and two from Chuanxiong (chlorogenic and cryptochlorogenic acid). Six of the seven compounds, excluding danshensu, inhibited the phosphorylation of ERK1/2. Both astragaloside II and chlorogenic acid upregulated the expression of SIRT2, and cryptochlorogenic acid and danshensu downregulated the expression of COX-2. CONCLUSIONS: The constituents of MD were firstly identified, and seven effective constituents were found. MD can protect SC against high-glucose and -lipid injury by downregulating ERK1/2 phosphorylation and COX-2 expression and upregulating SIRT2 expression. Seven effective constituents regulated the expression of these proteins. This study presented an important advance toward elucidating the chemical constituents, and the effective constituents and protective pathways of MD against high-glucose/lipid injury in SC, which is very helpful for investigating the action mechanism of MD on treating DPN, and could ultimately inform the development of effective quality control procedures for MD production.
引用
- Shi Y, Li H, Lin Y, et al. Effective constituents and protective effect of Mudan granules against Schwann cell injury. J Ethnopharmacol. 2024. PMID: 38176668. doi:10.1016/j.jep.2023.117692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。